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High-dose fentanyl has been widely used as a general anesthetic for patients
undergoing heart surgery. Fentanyl administered intravenously at the clinical dose
(4.5 µg/kg) has been shown to slightly decrease systemic blood pressure and
vascular resistance, whereas high doses (40-160 µg/kg) have been shown to
significantly decrease mean peripheral blood pressure.
1,2 In addition, the
hypotension produced by high-dose fentanyl (75 µg/kg) is associated with an
increased need for the use of alpha-adrenergic agonists to maintain blood
pressure.
3 Fentanyl has been shown to inhibit the α1-adrenoceptor agonist-induced
contraction in isolated aorta and pulmonary arteries.
4-6
The α1-adrenoceptors are a heterogeneous group of receptors and, based on
radioligand binding, molecular biology and isolated tissue experiments, they have
been classified into three subtypes: the α1A-, α1B- and α1D-adrenoceptors for native
receptors.
7 All three subtypes of the α1-adrenoceptors have a high affinity for the
non-subtype-selective α1-adrenoceptor antagonist prazosin,
7 and are expressed in
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Purpose: Fentanyl was reported to inhibit the α1-adrenoceptor agonist-induced contraction. The goal of this in vitro
study was to identify the α1-adrenoceptor subtype primarily involved in the fentanyl-induced attenuation of
phenylephrine-induced contraction in isolated endothelium-denuded rat aorta. Materials and Methods: Aortic rings
were suspended in order to record isometric tension. Concentration-response curves for phenylephrine (10
-9 to 10
-5
M) were generated in the presence or absence of one of the following drugs: fentanyl (3×10
-7, 10
-6, 3×10
-6 M), 5-
methylurapidil (3×10
-8, 10
-7, 3×10
-7 M), chloroethylclonidine (10
-5 M) and BMY 7378 (3×10
-9, 10
-8, 3×10
-8 M).
Phenylephrine concentration-response curves were generated in the presence or absence of fentanyl in rings
pretreated with either 3×10
-9 M prazosin, 10
-9 M 5-methylurapidil or 3×10
-9 M BMY 7378. Results: Fentanyl (10
-6,
3×10
-6 M) attenuated phenylephrine-induced contraction in the rat aorta. 5-Methylurapidil and BMY 7378
produced a parallel rightward shift in the phenylephrine concentration-response curve. The pA2 values for 5-
methylurapidil and BMY 7378 were estimated to be 7.71 ± 0.15 and 8.99 ± 0.24, respectively. Fentanyl (10
-6 M)
attenuated phenylephrine-induced contraction in rings pretreated with 10
-9 M 5-methylurapidil, but did not alter the
rings when pretreated with 3×10
-9 M BMY 7378. Pretreatment of the rings with chloroethylclonidine showed a
72.9 ± 2.3% reduction in phenylephrine-induced maximal contraction. Conclusion: The results suggest that
fentanyl attenuates phenylephrine-induced contraction by inhibiting the pathway involved in the α1D-adrenoceptor-
mediated contraction of the rat aorta.
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8 These
subtypes can be identified by selective and non-selective
antagonists. For example, 5-methyl-urapidil (5-MU) has a
10 to 50 times higher affinity for α1A-adrenoceptors, and the
affinity of BMY 7378 for α1D-adrenoceptors is at least 100-
fold higher.
8 Chloroethylclo-nidine (CEC) is an irreversible
antagonist that preferentially inactivates α1B-adrenoceptors,
but it can also partially inactivate α1D-adrenoceptors.
8 The
α1D-adrenoceptors mediate the phenylephrine-induced
contraction of the rat abdominal aorta, thoracic aorta, and
mesenteric artery,
9,10 and α1B-adrenoceptors mediate the
phenylephrine-induced contraction of the human umbilical
vein and canine pulmonary artery, as well as
phenylephrine-induced contraction in the dog aorta.
6,11,12
However, to the best of our knowledge, the α1-adrenoceptor
subtype that is involved in the fentanyl-induced attenuation
of the phenylephrine contraction-response curve in systemic
circulation such as rat aortas has not yet been identified.
The goals of the current in vitro study were to identify the
α1-adrenoceptor subtype that is involved mainly in the
fentanyl-induced attenuation of phenylephrine-induced
contraction in isolated endothelium-denuded rat aorta and to
characterize the α1-adrenoceptor subtype that is functionally
important in mediating the contractile response to
phenylephrine. 
All experimental procedures and protocols were approved
by the Institutional Animal Care and Use Committee.
Sprague-Dawley male rats, weighing 250-350 g each, were
anesthetized by the intraperitoneal administration of
pentobarbital sodium (50 mg/kg). The descending thoracic
aorta was dissected free, and the surrounding connective
tissue and fat were removed under microscopic guidance
while the blood vessels were bathed in Krebs solution of
the following composition: 118 mM NaCl, 4.7 mM KCl,
1.2 mM MgSO4, 1.2 mM KH2PO4, 2.4 mM CaCl2, 25 mM
NaHCO3, 11 mM glucose and 0.03 mM EDTA. The aorta
was then cut into 2.5-mm rings, which were suspended on
Grass isometric transducers (FT-03, Grass Instrument,
Quincy, MA, USA) with a 2.0 g resting tension in 10 mL
temperature-controlled baths (37˚C) containing the Krebs
solution, which was continuously gassed with 95% O2 and
5% CO2. The rings were equilibrated at a 2.0 g resting
tension for 120 min, during which time the bathing
solution was changed every 15 min. In all rings, the
endothelium was intentionally removed by inserting a 25-
G needle tip into the lumen of the rings and gently rolling
the rings for a few seconds. The contractile response
induced by isotonic 60 mM KCl was measured in each of
the aortic rings. 
Experimental protocol
The first series of these experiments was aimed at assessing
the effect of fentanyl on contractile response induced by the
α1-adrenoceptor agonist phenylephrine in endothelium-
denuded rings. Fentanyl was added directly to the organ
bath 30 min before cumulative phenylephrine-induced
contraction. The effect of fentanyl on the concentration-
response curves for phenylephrine (10
-9 to 10
-5 M) was
assessed by comparing the contractile response in the
presence or absence of fentanyl (3×10
-7, 10
-6, 3×10
-6 M). 
The second series of experiments was designed to deter-
mine which subtype of α1-adrenoceptor is functionally
important in mediating phenylephrine-induced contraction
in endothelium-denuded rat aorta. The effect of subtype-
selective α1-adrenoceptor antagonists (α1A-adrenoceptor
antagonist: 3×10
-8, 10
-7, 3×10
-7 M 5-MU; α1D-adre-
noceptor antagonist: 3×10
-9, 10
-8, 3×10
-8 M BMY 7378)
on the concentration-response curve for phenylephrine was
assessed by comparing each contractile response in the
presence and absence of each subtype-selective α1-adreno-
ceptor antagonist. The incubation period for each subtype-
selective α1-adrenoceptor antagonist was 30 min before
phenylephrine-induced contraction. 
The third series of experiments was designed to assess the
effect of the irreversible α1B-adrenoceptor antagonist CEC
on the concentration-response curve for phenylephrine. The
first concentration-response curve for phenylephrine was
constructed before pretreatment with 10
-5 M CEC. After
being washed, aortic rings were exposed to CEC (10
-5 M)
for a period of 20 min. Following removal of the CEC by
exchanges of the Krebs solution every 10 min for 1 hour, a
second concentration-response curve for phenylephrine was
constructed. 
In the fourth series of experiments, the α1-adrenoceptor
subtype dependence of fentanyl-induced attenuation of the
contractile response induced by phenylephrine was
examined. The effect of fentanyl (10
-6 M) on the concent-
ration-response curve for phenylephrine in the rings which
had been pretreated with either 10
-9 M 5-MU or 3×10
-9 M
BMY 7378 was assessed by comparing the contractile
response in the presence and absence of fentanyl (10
-6 M).
In addition, the role of the α1-adrenoceptor in the fentanyl-
induced attenuation of the contractile response induced by
phenylephrine was assessed by examining the phenyle-
phrine (10
-9 to 10
-4 M) concentration-response curve after
prazosin (3×10
-9 M) was added directly to organ bath,
either alone or in combination with fentanyl (3×10
-6 M).
The incubation period for the subtype-selective or non-
subtype-selective α1-adrenoceptor antagonists (3×10
-9 M
prazosin, 10
-9 M 5-MU and 3×10
-9 M BMY 7378) plus
fentanyl (10
-6, 3×10
-6 M) or α1-adrenoceptor antagonist
(subtype-selective or non-subtype-selective) alone was 30
min before the phenylephrine-induced contraction.  
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MATERIALS AND METHODSDrug and solution
All drugs used in the present study were of the highest
purity commercially available and included phenylephrine
HCl, acetylcholine, prazosin, 5-MU, CEC, BMY 7378 (8-
[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro
[4.5]decane-7,9-dione dihydrochloride) (Sigma Chemical,
St. Louis, MO, USA), and fentanyl (Hana Pharmaceutical
Co., Ltd., Seoul, Korea). All concentrations are expressed
as the final molar concentration in the organ bath. All drugs
were dissolved in distilled water. 
Data analysis 
The values are expressed as means ± SD. Contractile
responses to phenylephrine are expressed as a percentage of
their own maximum contraction to isotonic 60 mM KCl.
The first and second phenylephrine-induced contractions
are expressed as a percentage of the maximum obtained
from the first phenylephrine concentration-response curve.
The logarithm of the drug concentration (ED50), eliciting
50% of the maximum contractile response, was calculated
using nonlinear regression analysis by fitting the concen-
tration-response relation for phenylephrine to a sigmoidal
curve, by using commercially available software (Prism
version 3.02: GraphPad software, San Diego, CA, USA).
Data were fitted to a sigmoidal dose-response curve using
the following algorithm Y = Bottom + (Top - Bottom)/(1 +
10^ ((LogED50 - X) × Hill Slope)). The concentration ratio
(CR) is defined as the concentration of agonist required to
induce 50% maximal contractile response in the presence of
antagonist divided by the agonist concentration that elicits
the same degree of response in the absence of antagonist.
The pA2 value represents the concentration of antagonists
necessary to displace the concentration-response curve of
an agonist by twofold. Subtype-selective α1-adrenoceptor
antagonist pA2 values (-log M) were calculated from
Arunlakshana and Schild plots and were obtained from the
X-intercept of the plot of log (CR-1) against log molar anta-
gonist concentration, where the slope was not different from
unity.
13 The slope and pA2 values calculated from Arunlak-
shana and Schild plots are expressed as mean ± SEM.
13
Statistical analysis was performed using Student’s t-test for
paired comparison. One-way analysis of variance, followed
by Tukey’s multiple comparison, was used to compare
more than two means. The p value < 0.05 was considered
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Fig. 1. Effect of fentanyl on the phenylephrine dose-response curve in
endothelium-denuded rat aorta. Fentanyl (10
-6, 3×10
-6 M) produced a significant
rightward shift (ED50: *p < 0.05 versus no drug) in the phenylephrine dose-
response curve. Data are shown as mean ± SD and expressed as the
percentage of maximal contraction induced by isotonic 60 mM KCl (isotonic 60
mM KCl-induced contraction: 100% = 2.62  ±0.39 g [n = 7], 100% =  2.65 ±0.33 g [n
= 5], 100% = 2.67 ±0.37 g [n = 7] and 100% = 2.22 ± 0.29 g [n = 6] for the rings not
treated with fentanyl, the fentanyl [3 ×10
-7M], [10
-6M] and [3 ×10
-6M] pretreated
rings, respectively). 
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Fig. 2.(A) Effect of 5-methylurapidil (5-MU) on phenylephrine doe-response curve. 5-MU (3×10
-8, 10
-7, 3×10
-7 M) produced a parallel rightward shift (ED50: *p< 0.01 versus
no drug, �p< 0.001 versus 3×10
-8 M 5-MU, �p< 0.05 versus 10
-7 M 5-MU) in the phenylephrine dose-response curve in a concentration-dependent manner. Data are
shown as mean  ±SD and expressed as the percentage of maximal contraction induced by isotonic 60 mM KCl (isotonic 60 mM KCl-induced contraction: 100% = 3.30  ±
0.84 g [n = 5], 100% = 2.82 ±0.75 g [n = 5], 100% = 2.74  ±0.52 g [n = 5] and 100% = 2.38 ±0.71 g [n = 5] for the rings not treated with 5-MU, the 5-MU [3×10
-8M], [10
-7M] and
[3×10
-7 M] pretreated rings, respectively). (B) A Schild plot was constructed with the concentration ratio (CR: ED50 in the presence and absence of 5-MU) for individual
experiments. The slope of the Schild plot for 5-MU was 1.21 ± 0.23 (r
2 = 0.69), and the concentration (-log M) of 5-MU necessary to displace the phenylephrine
concentration-response curve by twofold was 7.71 ±0.15. 
ABsignificant. N refers to the number of rats whose descen-
ding thoracic aortic rings were used in each experiment.
Each group contained at least two rings from the same rat. 
Fentanyl (3×10
-7 M) did not significantly alter the pheny-
lephrine concentration-response curve (Fig. 1). However,
higher concentration of fentanyl (10
-6, 3×10
-6 M) signifi-
cantly attenuated (p < 0.05 versus no drug) phenylephrine-
induced contraction (ED50: no drug; -8.41 ± 0.34 versus 10
-6
M fentanyl; -7.84 ± 0.29, 3×10
-6 M fentanyl; -7.70 ± 0.28)
in endothelium-denuded rat aorta (Fig. 1).
Treatment of the aorta with 5-MU (3×10
-8, 10
-7, 3×10
-7
M) caused a parallel rightward shift (p < 0.01 versus no
drug) in the phenylephrine concentration-response curve
(ED50: no drug; -8.25 ± 0.19 versus 3×10
-8 M 5-MU; -7.81
± 0.13, 10
-7 M 5-MU; -7.23 ± 0.26, 3×10
-7 M 5-MU; -6.82
± 0.15) in a concentration-dependent manner (Fig. 2A).
Analysis of the data using an Arunlakshana and Schild plot
for the antagonism of phenylephrine-induced contraction
by 5-MU yielded a slope (1.21 ± 0.23) that was not signi-
ficantly different from unity (Fig. 2B). The pA2 value for 5-
MU was 7.71 ± 0.15 (Fig. 2B), which is approximately 10
times less than the reported affinity (9.3-8.4) for the α1A-
adrenoceptor, suggesting that the α1A-adrenoceptor subtype
does not play a main role in the phenylephrine-induced
contraction of the rat aorta.
8
BMY 7378 (3×10
-9, 10
-8, 3×10
-8 M) produced a parallel
rightward shift (p < 0.01 versus no drug) in the phenyle-
phrine concentration-response curve (ED50: no drug; -8.26
± 0.30 versus 3×10
-9 M BMY 7378; -7.63 ± 0.19, 10
-8 M
BMY 7378; -7.32 ± 0.23, 3×10
-8 M BMY 7378; -6.92×
0.14) in a concentration-dependent manner (Fig. 3A). The
Arunlakshana and Schild plot for antagonism of phenyle-
phrine-induced contraction by BMY 7378 yielded a slope
(0.87 ± 0.19) that was not significantly different from unity
(Fig. 3B). The pA2 value for BMY 7378 was 8.99 ± 0.24
(Fig. 3B), which is close to the reported affinity (8.7-8.1)
for the α1D-adrenoceptor, suggesting that the α1D-adreno-
ceptor plays a primary role in phenylephrine-induced
contraction of the rat aorta.
8
CEC (10
-5 M) produced 72.9% inhibition of the first
phenylephrine-induced maximal contraction (p < 0.0001
versus no drug) (Fig. 4), which suggests that phenyle-
phrine-induced contraction in the rat aorta involves the
CEC-sensitive α1-adrenoceptor subtype (α1B- and α1D-adre-
noceptors). 
Comparison with aortic rings not treated with fentanyl
showed that fentanyl (10
-6 M) significantly attenuated (p <
0.01 versus 5-MU alone) phenylephrine-induced contra-
ction (ED50: 10
-9 M 5-MU; -8.10 ± 0.24 versus 10
-9 M 5-MU
+ 10
-6 M fentanyl; -7.72 ± 0.24) in rings pretreated with 5-
MU at a concentration of 10
-9 M which is close to the
reported affinity (9.3-8.4) for the α1A-adrenoceptor (Fig. 5).
8
In rings pretreated with BMY 7378 at 3×10
-9 M concen-
tration which is close to the reported affinity (8.7-8.1) for
the α1D-adrenoceptor, fentanyl (10
-6 M) did not significantly
alter phenylephrine-induced contraction as compared with
rings not treated with fentanyl (Fig. 6).
8
Fentanyl (3×10
-6 M) had no effect on phenylephrine-
induced contraction of rings pretreated with prazosin (3×
10
-9 M) (Fig. 7).  
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Fig. 3. (A) Effect of BMY 7378 on phenylephrine does-response curve. BMY 7378 (3×10
-9, 10
-8, 3×10
-8 M) produced a parallel rightward shift (ED50: *p< 0.01 versus no
drug, �p< 0.001 versus 3 ×10
-9M BMY 7378, �p< 0.001 versus 10
-8M BMY 7378) in the phenylephrine dose-response curve in a concentration-dependent manner. Data
are shown as mean  ±SD and expressed as the percentage of maximal contraction induced by isotonic 60 mM KCl (isotonic 60 mM KCl-induced contraction: 100% =
3.03 ±0.81 g [n = 5], 100% = 2.90 ±0.31 g [n = 5], 100%  = 2.47 ±0.66 g [n = 5] and 100%  = 2.34 ±0.26 g [n = 5] for the rings not treated with BMY 7378, the BMY 7378 [3×10
-9
M], [10
-8M] and [3×10
-8M] pretreated rings, respectively). (B) A Schild plot was constructed with the concentration ratio (CR: ED50in the presence and absence of BMY
7378) for individual experiments. The slope of the Schild plot for BMY 7378 was 0.87 ±0.19 (r
2  = 0.62), and the concentration (-log M) of BMY 7378 necessary to displace
the phenylephrine concentration-response curve by twofold was 8.99 ±0.24.
RESULTS
A BDespite widespread use of fentanyl in patients undergoing
heart surgery, we believe that this is the first study to show
that fentanyl attenuates phenylephrine-induced contraction
by inhibiting the cellular signal transduction pathway
involved in the α1D-adrenoceptor-mediated contraction of
the rat aortic smooth muscle. The α1D-adrenoceptor exerts a
great influence on modulation of contraction induced by
phenylephrine in rat aortic smooth muscle.
Fentanyl attenuates phenylephrine-induced contraction in
the canine pulmonary artery by binding to the α1B-adreno-
ceptor,
6 and attenuates also the α1-adrenoceptor agonist
(phenylephrine and norepinephrine)-induced dose-response
curve by an alpha-adrenergic blocking action in isolated
rabbit and rat aorta.
4,5 Consistent with previous studies,
4-6
fentanyl (10
-6, 3×10
-6 M) attenuated phenylephrine-
induced contraction in the present study. In addition,
prazosin completely abolished fentanyl-induced attenuation
of contractile response induced by phenylephrine. These
results suggest that fentanyl attenuates the phenylephrine
dose-response curve by inhibiting α1-adrenoceptor-mediated
contraction of rat aortic smooth muscle. The CR which was
calculated as the ratio of the ED50 for phenylephrine in the
presence or absence of fentanyl (10
-6 M) was 2.52 ± 0.52,
suggesting that the dose of phenylephrine required for the
same magnitude of phenylephrine-induced contraction in
the presence of fentanyl (10
-6 M) is about 2.5 times higher
than that in the absence of fentanyl. Fentanyl (100 ng/mL)
Kyeong-Eon Park, et al.
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Fig. 7. Effect of fentanyl on the phenylephrine dose-response curve in rings
pretreated with 3×10
-9 M prazosin. Fentanyl (3 ×10
-6 M) had no effect on the
phenylephrine dose-response curve in the rings pretreated with 3×10
-9 M
prazosin. Data are shown as mean ± SD and expressed as the percentage of
maximal contraction induced by isotonic 60 mM KCl (isotonic 60 mM KCl-induced
contraction: 100% = 3.06 ± 0.32 g [n = 7] and 100% = 3.03 ± 0.55 g [n = 7] for the
rings not treated with fentanyl and the fentanyl [3 ×10
-6 M] pretreated rings,
respectively). 
Fig. 5. Effect of 10
-6 M fentanyl on phenylephrine dose-response curve in rings
pretreated with 10
-9 M 5-methylurapidil. Fentanyl (10
-6 M) attenuated (ED50: *p <
0.01 versus 10
-9 M 5-methylurapidil alone) phenylephrine-induced contraction
compared with rings pretreated with 10
-9 M 5-methylurapidil alone. Data are
shown as mean ± SD and expressed as the percentage of maximal contraction
induced by isotonic 60 mM KCl (isotonic 60 mM KCl-induced contraction: 100% =
2.71 ± 0.68 g [n = 9] and 100% = 2.98 ± 0.43 g [n = 9] for the rings not treated with
fentanyl and the fentanyl [10
-6M] pretreated rings, respectively). 
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Fig. 4. Effect of chloroethylclonidine (CEC) on phenylephrine dose-response
curve in endothelium-denuded rat aorta. The first phenylephrine dose-response
curves were obtained before (no drug) exposure to 10
-5M CEC. After aortic rings
were pretreated with 10
-5 M CEC for 20 min and washed intensively, second
dose-response curves for phenylephrine were obtained. CEC (10
-5 M) inhibited
maximal contraction induced by phenylephrine (*p < 0.0001 versus no drug).
Data are shown as mean ± SD and expressed as the percentage of the first
phenylephrine-induced maximal contraction (phenylephrine-induced maximal
contraction: 100% = 3.9 ±0.16 g [n = 4] for the rings with no drug).
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Fig. 6.Effect of 10
-6M fentanyl on the phenylephrine dose-response curve in rings
pretreated with 3×10
-9 M BMY 7378. Fentanyl (10
-6 M) did not significantly alter
pheny lephrine-induced contraction compared with rings pretreated with 3×10
-9
M BMY 7378 alone. Data are shown as mean ±SD and expressed as the percen-
tage of maximal contraction induced by isotonic 60 mM KCl (isotonic 60 mM KCl-
induced contraction: 100% = 2.89 ±0.33 g [n = 7] and 100% = 2.72 ±0.36 g [n = 7]
for the rings not treated with fentanyl and the fentanyl [10
-6 M] pretreated rings,
respectively). 
DISCUSSIONinduces a small, but statistically significant attenuation of
the phenylephrine concentration-response curve in isolated
endothelium-intact canine coronary arteries.
14 However, the
present study showed that fentanyl at a concentration of 3
×10
-7 M, which corresponds approximately to the plasma
concentration (100 ng/mL) occurring in patients anesthetized
with fentanyl for major surgery, had no effect on phenyle-
phrine-induced contraction.
3 The discrepancy in the results
of the two studies may be ascribed to the difference in the
vessel selected (endothelium-intact canine coronary artery
versus endothelium-denuded rat aorta).    
The estimated affinity of 5-MU for the α1A-adrenoceptor
is approximately 10 times greater than that for the α1D-
adrenoceptor and 100 times greater than that for the α1B-
adrenoceptor.
15,16  In the present in vitro study, the affinity of
5-MU estimated in the rat aorta (pA2 = 7.71 ± 0.15) was
close to the value expected for an interaction with the α1D-
adrenoceptor (7.80 ± 0.09, 7.91 ± 0.07) rather than the α1A-
adrenoceptor (8.50 ± 0.09, 8.68 ± 0.09) or α1B-adrenoceptor
(6.80 ± 0.13, 6.76 ± 0.17).
15,16 BMY 7378 is a selective α1D-
adrenoceptor antagonist, whose selectivity for α1D-adreno-
ceptor is 100 times greater than that for the α1A- or α1B-
adrenoceptor.
15,17 In this study, the estimated affinity of
BMY 7378 was 8.99 ± 0.24, which is close to pKi values for
the human recombinant α1D-adrenoceptor expressed in rat-
1 fibroblast (9.39 ± 0.05) and the rat aorta (8.88 ± 0.10),
demonstrating predominance of the α1D-adrenoceptor
subtype.
18 These results suggest that phenylephrine-induced
contraction in rat aortic smooth muscle is primarily media-
ted by the α1D-adrenoceptor. The agreement between agonist
potency and affinity for the α1D-adrenoceptor binding site
shows that the α1D-adrenoceptor is responsible for media-
ting contraction of the rat aorta.
19 The phenylephrine-
induced contraction of the rat thoracic aorta is mainly
mediated by the α1D-adrenoceptor.
9,20,21 Consistent with
previous studies,
9,19-21 the present results suggest that the
α1D-adrenoceptor is functionally important in mediating the
phenylephrine-induced contraction of the rat aorta. Fentanyl
(10
-6 M) attenuated phenylephrine-induced contraction in
rings when pretreated with 10
-9 M 5-MU, but it did not
significantly alter phenylephrine-induced contraction in
rings pretreated with 3×10
-9 M BMY 7378. Together with
the present results suggesting that the α1D-adrenoceptor is
mainly involved in phenylephrine-induced contraction,
these results suggest that fentanyl attenuates phenylephrine-
induced contraction by inhibiting α1D-adrenoceptor-mediated
contraction in the rat aorta. However, to lessen overesti-
mation that may occur from concentration of 5-methylu-
rapidil (10
-9 M) and BMY 7378 (3×10
-9 M) adopted from
previously reported pA2 values, competitive binding studies
with radioisotope-tagged drugs are needed to examine the
direct effect of fentanyl on α1-adrenoceptor subtypes (α1A
and α1D).
8 In a radioligand binding study involving 20-min
incubation at 37˚C, the α1B-adrenoceptor was preferentially
(89 to 98%) inactivated by the irreversible α1B-adrenoceptor
antagonist (10
-4 M CEC), followed by α1D-adrenoceptor at
75 to 86% and α1A-adrenoceptor at 11 to 18%.
22 Rat aortic
rings exposed to CEC (5×10
-6 M) show 20% reduction in
phenylephrine-induced contraction.
23 However, inhibition
of contraction by pretreatment with 10
-5 M CEC (20 min)
was 72.9 ± 2.3% in this in vitro study. This different effect
of CEC on phenylephrine-induced contraction may be
ascribed to the difference in the concentration of CEC,
incubation period and washing method with fresh Krebs
solution. CEC has been used extensively as a tool to
discriminate α1A-adrenoceptor (CEC-insensitive) from α1B-
and α1D-adrenoceptors (CEC-sensitive).
8 Pretreatment of rat
aorta with CEC (3×10
-5 M) showed 83.9% reduction of
phenylephrine-induced contraction, which suggests that α1-
adrenoceptor subtype of the rat aorta is CEC-sensitive
subtype (α1B- and α1D-adrenoceptors).
24 Based on the
findings of current and previous studies, CEC-sensitive
α1D-adrenoceptor appears to be involved in the phenyle-
phrine-induced contraction of the rat aorta.
8,24 Interestingly,
α1-adrenoceptors seem to be regulated by crosstalk between
G-protein-coupled receptors and subsequent signaling
cascades.
25 Further investigation is needed in order to
determine the effect of fentanyl on G-protein, phospholipase
C, the coupling processes, inositol 1,4,5-triphosphate and
diacylglycerol, since all these factors are involved in the
cellular signal transduction pathway for α1D-adrenoceptor-
mediated phenylephrine-induced contraction.   
Fentanyl (2.97×10
-6 M) attenuates the nitric oxide-
mediated relaxation induced by acetylcholine,
26 and
produces hypotension by inhibiting central sympathetic
outflow in intact dogs anesthetized with enflurane.
27
Previous studies have shown that fentanyl has no effect on
myocardial contractility at a clinical dose and increases
myocardial contractile force at supraclinical doses.
28,29
According to the findings described above, the net hemody-
namic effect of fentanyl in vivo is a composite of the effect
of fentanyl on blood vessel, central sympathetic activity
and the heart.
26-29 Any clinical implications of fentanyl on
regional hemodynamics must be tempered by the fact that a
large conduit artery, the aorta, was used in this in vitro
experiment, whereas the resistance vessels with the arteri-
oles of a diameter of 100-300 µm control most organ blood
flow.
30 Even with these limitations, since 3×10
-7 M fentanyl
(plasma fentanyl concentration 100 µg/mL) did not alter
phenylephrine-induced contraction, the indirect mechanism
for vasodilation, which is mediated by decreased central
sympathetic outflow induced by fentanyl, might be invol-
ved in the hypotension observed in the previous in vivo
studies.
1-3,27
Fentanyl significantly attenuated phenylephrine-induced
contraction at concentrations of 10
-6 and 3×10
-6 M, which
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-8
M).
3 However, the rapid redistribution of fentanyl (octanol:
water partition coefficient = 813) to lipid-rich tissue may
create a discrepancy between the serum concentration and
actual tissue concentration.
31 Because cerebrospinal fluid
contains very little protein in comparison to plasma, the
average concentration of active fentanyl in cerebrospinal
fluid is approximately 46% of the total plasma fentanyl
concentration, which is more than twice the free fraction of
plasma fentanyl.
32,33 Small changes in the amount or binding
capacity of proteins in certain pathologic conditions
(example: liver disease, hemodilution, hypoproteinemia)
could result in an increase in the free fraction of fentanyl.
Taking the above findings into consideration, the 10
-6 M
concentration of fentanyl required for an inhibitory effect
on phenylephrine-induced contraction might be the concen-
tration encountered in clinical settings.
31-33
In conclusion, the present results suggest that fentanyl at
supraclinical dose (10
-6 M) attenuates phenylephrine-induced
contraction of rat aortic smooth muscle by inhibiting the
pathway involved in the α1D-adrenoceptor-mediated contrac-
tion. In addition, the α1D-adrenoceptor is functionally impor-
tant in mediating phenylephrine-induced contraction of
isolated rat aorta. 
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